NCT05791513

Brief Summary

The aim of the stepped-wedge cluster randomised trial is to investigate the effectiveness of using a clinical support tool (The MAP-Knee Tool) in managing adolescents aged 10-19 years with non-traumatic knee pain compared to not using the tool. Six participating hospitals will start to use the tool within 4, 6, or 8 months after recruitment start in a randomised order. We will investigate if using the tool is superior in terms of reducing symptoms compared to not using the tool.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2025

Completed
Last Updated

June 4, 2025

Status Verified

June 1, 2025

Enrollment Period

1.2 years

First QC Date

March 17, 2023

Last Update Submit

June 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • KOOS-Child Pain subscale

    KOOS-Child consists of 39 items divided into five subscales (Pain, Symptoms, Activities of Daily Living, Sport/Recreation, and Quality of Life) that each range from 0 to 100 with 100 being optimum. This questionnaire has been found to have good psychometric properties and is recommended for children and adolescents suffering from knee disorders.

    During baseline and at the 12-week and 52-week follow-ups

Secondary Outcomes (8)

  • KOOS-Child Symptoms subscale

    During baseline and at the 12-week and 52-week follow-ups

  • KOOS-Child Activities of daily living subscale

    During baseline and at the 12-week and 52-week follow-ups

  • KOOS-Child Sport/recreation subscale

    During baseline and at the 12-week and 52-week follow-ups

  • KOOS-Child Quality of Life subscale

    During baseline and at the 12-week and 52-week follow-ups

  • EQ-5D-Y

    During baseline and at the 12-week and 52-week follow-ups

  • +3 more secondary outcomes

Other Outcomes (1)

  • Anterior Knee Pain Youth (AKP-Youth)

    During baseline and at the 12-week and 52-week follow-ups

Study Arms (2)

Using the MAP-Knee Tool

EXPERIMENTAL

The treating clinician will use the MAP-Knee Tool together with the adolescent. The tool includes four separate components: 1) a tool for diagnosing the most common types of non-traumatic knee pain (SMILE), 2) credible explanations of the aetiology and pathogenesis specific to the diagnosis based on multiple methods with an iterative design, 3) a presentation of prognostic factors based on an individual participant data meta-analysis(19), and 4) an option grid that presents the users of the tool with pros and cons of commonly used management options based on a systematic literature search of systematic and narrative reviews within non-traumatic adolescent knee pain. An overarching focus of all components was to support shared decision-making and base decisions on all three pillars of evidence-based medicine: patient values, clinical expertise, and relevant research. Therefore, the tool should not provide the users with definitive answers simply based on available evidence.

Other: Using the MAP-Knee Tool

Not using the MAP-Knee Tool

ACTIVE COMPARATOR

The treating clinician will not use the MAP-Knee Tool in the consultation and will conduct the consultation as per usual practice.

Other: Usual practice

Interventions

Using the MAP-Knee Tool

Using the MAP-Knee Tool

The consultation between clinician and adolescent is conducted as per usual practice.

Not using the MAP-Knee Tool

Eligibility Criteria

Age10 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Having been referred to a hospital due to non-traumatic knee pain
  • Age between 10 and 19 years

You may not qualify if:

  • Knee pain with a traumatic origin
  • Lack of ability to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Aalborg Universitetshospital

Aalborg, Denmark

Location

Amager-Hvidovre Hospital

Copenhagen, Denmark

Location

Bispebjerg Hospital

Copenhagen, Denmark

Location

Sportsmedicinsk Center

Frederikshavn, Denmark

Location

Næstved Sygehus

Næstved, Denmark

Location

Vejle Sygehus

Vejle, Denmark

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Stepped-wedge randomised trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2023

First Posted

March 30, 2023

Study Start

May 10, 2023

Primary Completion

July 16, 2024

Study Completion

April 26, 2025

Last Updated

June 4, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

De-identified data will be made available upon reasonable request.

Locations